Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Astellas launches behavioral science initiative to promote early bladder cancer diagnosis
Astellas Pharma has initiated a global campaign to address the critical issue of delayed bladder cancer diagnoses. In collaboration with the World...
Three NWO grants for Leiden researchers exploring the unknown
Pioneering research at Leiden Faculty of Science awarded NWO grants Three bold ideas, one shared goal: advancing science for a better future From...
Two new arrivals boost AI and regulatory strength in the park
From therapeutic mini proteins to pharma compliance services, international life sciences companies are choosing Leiden as the place to grow. Among...
A day of discovery at Biotech Training Facility with Merck on Tour
The Biotech Training Facility at Leiden Bio Science Park welcomed the Merck on Tour mobile lab, a travelling showcase of the latest life science...
MIMETAS publishes breakthrough study on human artery-on-a-chip model
MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular...
Azafaros secures €132 million in series B financing to advance phase 3 programs
Azafaros has raised €132 million in an oversubscribed Series B financing round. The funding will support the advancement of its lead clinical-stage...
Leiden researchers awarded funding for high-tech research
Two Leiden University research teams have been awarded grants through the HTSM programme, supporting advanced technology development with strong...
Leiden’s PERISCOPE AI model predicts postoperative infection risks
Researchers at Leiden University Medical Center (LUMC) have developed PERISCOPE, an AI-driven tool designed to predict the risk of infections in...
NecstGen and Astraveus explore benchtop CAR-T manufacturing
NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to...